Investegate |Idorsia Pharmaceuticals Ltd Announcements | Ido

Investegate announcements from Idorsia Pharmaceuticals Ltd, Idorsia submits a New Drug Application to the US FDA for aprocitentan for the treatment of patients with difficult-to-control hypertension

Related Keywords

Australia , United States , Allschwil , Switzerland General , Switzerland , Dublin , Ireland , America , American , Swiss , Andrewc Weiss , Clozelm Aprocitentan , Jean Paul Clozel , Markus Schlaich , Arterioscler Thromb Vasc , J Physiol Pharmacol , Idorsia Ltd , American Heart Association , Head Of Investor Relations Corporate Communications , Janssen Biotech Inc , Drug Administration , Swiss Exchange , Janssen Pharmaceutical Companies Of Johnson , Idorsia Pharmaceuticals Ltd , New Drug Application , Late Breaking Science , Scientific Sessions , Paul Clozel , Chief Executive Officer , Janssen Pharmaceutical Companies , Janssen Biotech , African American , North America , Pressure Lowering Treatment Trialist , Heart Journal , Scientific Statement From , American Heart , Rev Pharmacol , Factor Collaboration , Thromb Vasc Biol , Clin Hypertension , Vice President , Investor Relations , Pharmaceuticals Ltd , Investegate Announcements , Investegate Company Announcements , Lobenewswire , Lobenewswire And Globenewswire , Nw ,